Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
CPRIT CEO highlights annual report and staffing; CFO reports $11 million in revenue sharing, Welareg royalties rising
Summary
CPRIT Chief Executive Officer Kristin Doyle presented the annual report and legislative and staffing updates while Chief Financial Officer Grant Weaver reported roughly $11 million in revenue sharing since inception, about $4.5 million from royalties on the drug Welareg, and recent bond issuance activity.
Kristin Doyle, chief executive officer of the Cancer Prevention and Research Institute of Texas, used her CEO report to highlight CPRIT’s 2024 annual report, staffing levels, and recent legislative activity; Chief Financial Officer Grant Weaver summarized revenue sharing, royalties and bond issuances.
Why it matters: The CEO and CFO updates provide oversight committee members and the public with the agency’s fiscal status, staffing constraints, legislative engagement and measures of program impact — information that shapes the agency’s budget requests and operational planning.
CEO update: Doyle said the agency timed the annual CEO report to follow publication of CPRIT’s 2024 Texas cancer plan and highlighted the agency’s grant portfolio and program impact. She told the committee…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
